Ionis Investigative Site

Dallas, Texas 75390

0 studies enrolling now · 7 studies all time

What they study most

Age Related Macular Degeneration, Familial Partial Lipodystrophy, Geographic Atrophy, Hereditary Angioedema, Lafora Disease, Macular Degeneration

Studies at this site

• An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema — Completed
• A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE) — Running, not enrolling
• GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD) — Completed
• OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE) — Completed
• Natural History and Functional Status Study of Patients With Lafora Disease — Completed
• The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial Lipodystrophy — Stopped early
• Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Withdrawn before enrolling